Bioavailability of the fixed dose formulation Rifafour containing isoniazid, rifampicin pyrazinamide, ethambutol and the World Health Organization (WHO) recommended first line antiretroviral drugs zidovudine, lamivudine, efavirenz administered to new Tuberculosis (TB) patients at different levels of immunosuppression Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An evaluation of the impact of early initiation of Highly Active Anti-Retroviral Therapy (HAART) on Tuberculosis (TB) treatment outcomes for TB patients co-infected with Human Immunodeficiency Virus (HIV) Not provided at time of registration

• Pays South Africa, Tanzania, United Republic of, Uganda, Zambia
• Organes Aucun
• Spécialités Aucune